Although clinical trials are meant to cover global populations, the pool of patients currently enrolled in clinical trials is not representative of world populations. The vast majority of patients recruited in clinical trials undoubtedly comes from the European Union and North America.
Rising costs and complexity in clinical research have led to an intensification of protocol inclusion/exclusion criteria that make clinical trials inaccessible to most people. In order to broaden the recruitment of patients enrolled in clinical trials, clinical research opportunities in remote areas must be increased. The inclusion/exclusion criteria should be made more flexible and regulatory requirements ought to be harmonized by the competent authorities.
Today, clinical trials are not conducted in a format that secures full representation of people and their cultural differences.
How can technology contribute to running truly global clinical trials?
Read the full article on:
